Targeted activation of human Vγ9Vδ2-T cells controls epstein-barr virus-induced B cell lymphoproliferative disease.
Xiang Z, Liu Y, Zheng J, Liu M, Lv A, Gao Y, Hu H, Lam KT, Chan GC, Yang Y, Chen H, Tsao GS, Bonneville M, Lau YL, Tu W.
Xiang Z, et al. Among authors: tu w.
Cancer Cell. 2014 Oct 13;26(4):565-76. doi: 10.1016/j.ccr.2014.07.026. Epub 2014 Sep 11.
Cancer Cell. 2014.
PMID: 25220446
Free article.